UPDATE : Tuesday, September 17, 2019
상단여백
Allergan to resume marketing of macular edema treatment by Lee Han-soo 2019-03-27 16:55
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe by Jeong Sae-im 2019-03-27 16:16
FDA OKs CrystalGenomics’ P1 trial for leukemia treatment by Lee Han-soo 2019-03-27 15:58
‘Remimazolam has fewer side effects than propofol’ by Jeong Sae-im 2019-03-27 15:05
CJ Healthcare releases P3 trial results for gastroesophageal reflux treatment by Lee Han-soo 2019-03-27 14:52
라인
AstraZeneca to launch Imfinzi in Korea next month by Lee Han-soo 2019-03-27 14:52
Hanlim Pharm seeks to expand HL301’s indication for radiation pneumonitis by Lee Hye-seon 2019-03-26 15:57
Doctors outrageous over MSD Korea’s recordings of their talks by Park Gi-taek 2019-03-25 16:05
Daewoong releases P3 trial results for Nabota by Lee Han-soo 2019-03-25 15:01
Regulator OKs immunotherapies developed by multinational pharma companies by Lee Han-soo 2019-03-25 11:28
라인
Otsuka Korea CEO receives presidential citation by Lee Han-soo 2019-03-22 16:52
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials by Kim Yun-mi 2019-03-22 15:50
Eubiologics gets nod to test botulinum toxin in phase-1 study by Lee Hye-seon 2019-03-22 15:28
‘MSD Korea excessively monitors workers, collects client info without consent’ by Jeong Sae-im 2019-03-22 13:49
AbClon, C&R Research sign CRO contract by Lee Han-soo 2019-03-21 17:17
라인
2 drugs for enlarged prostate not different in depression risk by Lee Hye-seon 2019-03-21 16:51
SK Biopharmaceutical’s US partner gets FDA nod for sleepiness treatment by Lee Han-soo 2019-03-21 15:26
LG Chem licenses in PDC line’s anti-cancer vaccine by Lee Han-soo 2019-03-21 11:17
UK regulator OKs P1 trials of Shin Poong’s thrombotic disease treatment by Jeong Sae-im 2019-03-20 16:22
Medytox launches 3rd BTX product by Lee Han-soo 2019-03-20 11:29
여백
여백
여백
Back to Top